FDA approves Vabysmo for treatment of wet AMD, DME

The FDA has approved Vabysmo for the treatment of wet age-related macular degeneration and diabetic macular edema, according to a press release from Genentech. Vabysmo (faricimab-svoa) is an injectable eye medicine…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.